View Author
patient disease pompe disease pompe muscle study function adult therapy muscle strength group treatment enzyme position children alglucosidase alfa strength van der ploeg glycogen range hearing storage activity supine position alglucosidase score scale van doorn pa course effect follow-up weakness late-onset pompe disease muscle weakness van der beek supine value sumscore result hearing loss motor duration glucosidase late-onset motor function test reuser enzyme-replacement therapy change diagnosis enzyme replacement therapy support reuser aj ploeg lysosomal measurement disorder table enzyme therapy disease duration deficiency mutation ventilation month metab erasmus mc university severity acid α- glucosidase difference disease progression mrc sumscore infantile-onset pompe disease wheelchair outcome decline symptom analysis involvement baseline hageman neurology
10 Most Recent Publications
|
Clinical features, disease course, and effects of enzyme therapy in Pompe disease
(Doctoral Thesis)
Beek, N.A.M.E. van der |
2013-04-23
|
|
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: An open-label single-center study
(Article)
Vries, J.M. de Beek, N.A.M.E. van der Faber, C.G. Verschuuren, J.J. Kruijshaar, M.E. Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Hop, W.C.J. Karstens, F.P. Wokke, J.H.J. Visser, M. de Engelen, B.G. van Kuks, J.B.M. Kooi, A.J. van der Notermans, N.C. |
2012-09-28
|
|
Hearing in adults with Pompe disease
(Article)
Beek, N.A.M.E. van der Verschuure, H. Reuser, A.J.J. Ploeg, A.T. van der Doorn, P.A. van Poublon, R.M.L. |
2011-10-14
|
|
The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients
(Article)
Capelle, C.I. van Beek, N.A.M.E. van der Vries, J.M. de Doorn, P.A. van Duivenvoorden, H.J. Leshner, R.T. Hagemans, M.L.C. Ploeg, A.T. van der |
2011-09-13
|
|
Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease
(Article)
Beek, N.A.M.E. van der Capelle, C.I. van Velden-van Etten, K.I. van der Hop, W.C.J. Berg, B. van den Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Stam, H. |
2011-09-01
|
|
Burden of illness of Pompe disease in patients only receiving supportive care
(Article)
Kanters, T.A. Hagemans, M.L.C. Beek, N.A.M.E. van der Rutten, F.F.H. Ploeg, A.T. van der Hakkaart-van Roijen, L. |
2011-04-18
|
|
High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
(Article)
Vries, J.M. de Beek, N.A.M.E. van der Kroos, M.A. Özkan, L. Doorn, P.A. van Richards, S.M. |
2010-12-01
|
|
Effect of enzyme therapy in juvenile patients with Pompe disease: A three-year open-label study
(Article)
Capelle, C.I. van Beek, N.A.M.E. van der Puga, A.C. Reuser, A.J.J. Ploeg, A.T. van der Hagemans, M.L.C. Arts, W.F.M. Hop, W.C.J. Lee, P. Jaeken, J. Frohn-Mulder, I.M.E. Merkus, P.J.F.M. Corzo, D. |
2010-12-01
|
|
PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease
(Article)
Hagemans, M.L.C. Stigter, R.L. Capelle, C.I. van Beek, N.A.M.E. van der Winkel, L.P.F. Vliet, L. van Hop, W.C.J. Reuser, A.J.J. Beishuizen, A. Ploeg, A.T. van der |
2010-04-01
|
|
Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates
(Article)
Diggelen, O.P. van Oemardien, L.F. Beek, N.A.M.E. van der Kroos, M.A. Wind, H.K. Voznyi, Y.V. Burke, D. Jackson, M. Winchester, B. Reuser, A.J.J. |
2009-04-23
|